Faculty Opinions recommendation of A phase 2 randomized, double-blind, placebo-controlled study of the safety and efficacy of talactoferrin in patients with severe sepsis.

2013 ◽  
Author(s):  
Walter Hasibeder
Keyword(s):  
Severe Sepsis ◽  
Controlled Study ◽  
Phase 2 ◽  
Double Blind ◽  
Safety And Efficacy ◽  
Double Blind Placebo

A Phase 2 Randomized, Double-Blind, Placebo–Controlled Study of the Safety and Efficacy of Talactoferrin in Patients With Severe Sepsis*

2013 ◽  
Vol 41 (3) ◽  
pp. 706-716 ◽  
Author(s):  
Kalpalatha Guntupalli ◽  
Nathan Dean ◽  
Peter E. Morris ◽  
Venkata Bandi ◽  
Benjamin Margolis ◽  
...  
Keyword(s):  
Severe Sepsis ◽  
Controlled Study ◽  
Phase 2 ◽  
Double Blind ◽  
Safety And Efficacy ◽  
Double Blind Placebo

OP0024 Safety and efficacy of SBI-087 in subjects with active rheumatoid arthritis in a phase 2 randomized, double-blind, placebo-controlled study

2013 ◽  
Vol 71 (Suppl 3) ◽  
pp. 60.3-61
Author(s):  
N. Damjanov ◽  
M. Tlustochowicz ◽  
J. Aelion ◽  
A. Dimic ◽  
M. Greenwald ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Active Rheumatoid Arthritis ◽  
Controlled Study ◽  
Phase 2 ◽  
Double Blind ◽  
Safety And Efficacy ◽  
Double Blind Placebo

scholarly journals The Safety and Efficacy of Microbial Ecosystem Therapeutic-2 (MET-2) in People with Major Depression: Protocol for a Phase 2, Double-blind, Placebo-controlled Study (Preprint)

10.2196/31439 ◽  
2021 ◽  
Author(s):  
Arthi Chinna Meyyappan ◽  
Cassandra Sgarbossa ◽  
Gustavo Vazquez ◽  
David J. Bond ◽  
Daniel J. Müller ◽  
...  
Keyword(s):  
Major Depression ◽  
Controlled Study ◽  
Phase 2 ◽  
Double Blind ◽  
Microbial Ecosystem ◽  
Safety And Efficacy ◽  
Double Blind Placebo

929a A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 in Patients with Diabetic Gastroparesis

2014 ◽  
Vol 146 (5) ◽  
pp. S-158-S-159 ◽  
Author(s):  
Anthony Lembo ◽  
Michael Camilleri ◽  
Richard W. McCallum ◽  
Ramon F. Sastre ◽  
Cristian F. Breton ◽  
...  
Keyword(s):  
Diabetic Gastroparesis ◽  
Controlled Study ◽  
Phase 2 ◽  
Double Blind ◽  
Safety And Efficacy ◽  
Double Blind Placebo

Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study

2014 ◽  
Vol 13 (9) ◽  
pp. 885-892 ◽  
Author(s):  
David W Dodick ◽  
Peter J Goadsby ◽  
Egilius L H Spierings ◽  
Joel C Scherer ◽  
Steven P Sweeney ◽  
...  
Keyword(s):  
Monoclonal Antibody ◽  
Calcitonin Gene Related Peptide ◽  
Controlled Study ◽  
Phase 2 ◽  
Double Blind ◽  
Safety And Efficacy ◽  
Double Blind Placebo ◽  
Related Peptide ◽  
Calcitonin Gene
Sign in / Sign up

Export Citation Format

Share Document